The future of global health: Personalized medicine at RGHS

 

Kevin Hrusovsky, president of PerkinElmer Life Sciences and Technology, gives a keynote entitled "Our Crusade to Revolutionize and Personalize Global Health" at the Revolutionaries for Global Health Summit held October 24-25 in San Francisco.

Kevin Hrusovsky, president of PerkinElmer Life Sciences and Technology, gives a keynote

entitled "Our Crusade to Revolutionize and Personalize Global Health" at the Revolutionaries for Global Health Summit

held October 24-25 in San Francisco. 

 

The Revolutionaries for Global Health Summit, held October 24 and 25 in San Francisco, saw the gathering of medical researchers, scientific visionaries and PerkinElmer leaders. The summit was one event of a series of worldwide PerkinElmer-sponsored conferences being held to facilitate the meeting of the greatest and most innovative minds in medical research, with the aim to encourage momentum toward the goal of cancer eradication through collaborative learnings amongst scientists and scientific tool providers.

Presented by Life Sciences and Technology’s president, Kevin Hrusovsky, the summit’s keynote speech entitled “Our Crusade to Revolutionize and Personalize Global Health” asked PerkinElmer scientists, customers and colleagues in medical, pharmaceutical and biotechnology industries to champion collaboration to achieve worldwide cancer eradication and improve diagnostic and patient treatment processes through efforts to personalize global health practices.

Crucial to the practice of personalized healthcare, Hrusovsky explained, is the understanding of how environmental macrofactors and genetic microfactors interact and affect disease development and treatment. To facilitate the study of epigenetics, Hrusovsky sees informatics as a crucial bridge between researchers and scientific institutions located across developed and emerging countries, enabling the flow of information necessary to analyze and understand universal biomarkers, biological mechanisms and environmental factors that influence disease diagnosis, progression and treatment.

The future of global health lies in the application of epigenetics findings and informatics analyses to establish better research methods, prevention guidelines, diagnostic tools and processes, treatments and drug therapies targeting diseases such as cancer, diabetes and heart disease. Achieving these goals will improve diagnosis accuracy and provide personalized treatment options, resulting in increased drug therapy efficacy and reduced toxicity and side effects.

The next Revolutionaries for Global Health Summit will be held November 15-16 in Tokyo. To register for the event, click here.

To watch a video recording of Hrusovsky’s keynote and to see other presentations given at the San Francisco summit, click here.

Loading